Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Rizzo

Showing results (281-290 of 381) with videos related to

Pageof 39
Sort By:
Expert Review of Anticancer Therapy|August 8, 2020
Combination therapy in advanced urothelial cancer: the role of PARP, HER-2 and mTOR inhibitorsVeronica Mollica, Ilaria Maggio, Antonio Lopez-Beltran, et al.
Cancer Treatment Reviews|September 23, 2025
Datopotamab deruxtecan: rational strategies, novel advancements, challenges, and future perspectivesVincenzo Di Lauro, Alessandro Rizzo, Margherita Tafuro, et al.
Cancer Medicine|December 18, 2024
Monitoring Over Time of Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer Patients Through an Ensemble Vision Transformers-Based ModelMaria Colomba Comes, Annarita Fanizzi, Samantha Bove, et al.
International Journal of Molecular Sciences|July 27, 2024
Autotaxin-Lysophosphatidate Axis: Promoter of Cancer Development and Possible Therapeutic ImplicationsCarmelo Laface, Angela Dalia Ricci, Simona Vallarelli, et al.
Clinical & Experimental Metastasis|March 31, 2026
Nal-IRI (liposomal irinotecan) plus 5-fluorouracil and leucovorin versus 5-fluorouracil for metastatic pancreatic ductal adenocarcinoma following gemcitabine-based therapy. A systematic review and meta-analysis of randomized controlled trialsElsa Vitale, Alessandro Rizzo, Lorenza Maistrello, et al.
Journal of Clinical Medicine|April 3, 2021
Gene Expression Landscape of SDH-Deficient Gastrointestinal Stromal TumorsValentina Indio, Angela Schipani, Margherita Nannini, et al.
Cancers|February 4, 2021
Bone Targeting Agents in Patients with Metastatic Prostate Cancer: State of the ArtVeronica Mollica, Alessandro Rizzo, Matteo Rosellini, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 20, 2026
Asthenia in cancer patients receiving immune checkpoint Inhibitors (ICIs): the MOUSEION-11 systematic review and meta-analysisElsa Vitale, Andrey Soares, Alessandro Rizzo, et al.
Anticancer Research|February 5, 2020
Specific Toxicity of Maintenance Olaparib <i>Versus</i> Placebo in Advanced Malignancies: A Systematic Review and Meta-analysisAngela Dalia Ricci, Alessandro Rizzo, Marco Novelli, et al.
Cancers|May 28, 2022
Immunotherapy in Pancreatic Cancer: Why Do We Keep Failing? A Focus on Tumor Immune Microenvironment, Predictive Biomarkers and Treatment OutcomesAlessandro Di Federico, Mirta Mosca, Rachele Pagani, et al.
Pageof 39

Showing results (281-290 of 381) with videos related to

Sort By:
Pageof 39
Expert Review of Anticancer Therapy|August 8, 2020
Combination therapy in advanced urothelial cancer: the role of PARP, HER-2 and mTOR inhibitorsVeronica Mollica, Ilaria Maggio, Antonio Lopez-Beltran, et al.
Cancer Treatment Reviews|September 23, 2025
Datopotamab deruxtecan: rational strategies, novel advancements, challenges, and future perspectivesVincenzo Di Lauro, Alessandro Rizzo, Margherita Tafuro, et al.
Cancer Medicine|December 18, 2024
Monitoring Over Time of Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer Patients Through an Ensemble Vision Transformers-Based ModelMaria Colomba Comes, Annarita Fanizzi, Samantha Bove, et al.
International Journal of Molecular Sciences|July 27, 2024
Autotaxin-Lysophosphatidate Axis: Promoter of Cancer Development and Possible Therapeutic ImplicationsCarmelo Laface, Angela Dalia Ricci, Simona Vallarelli, et al.
Clinical & Experimental Metastasis|March 31, 2026
Nal-IRI (liposomal irinotecan) plus 5-fluorouracil and leucovorin versus 5-fluorouracil for metastatic pancreatic ductal adenocarcinoma following gemcitabine-based therapy. A systematic review and meta-analysis of randomized controlled trialsElsa Vitale, Alessandro Rizzo, Lorenza Maistrello, et al.
Journal of Clinical Medicine|April 3, 2021
Gene Expression Landscape of SDH-Deficient Gastrointestinal Stromal TumorsValentina Indio, Angela Schipani, Margherita Nannini, et al.
Cancers|February 4, 2021
Bone Targeting Agents in Patients with Metastatic Prostate Cancer: State of the ArtVeronica Mollica, Alessandro Rizzo, Matteo Rosellini, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 20, 2026
Asthenia in cancer patients receiving immune checkpoint Inhibitors (ICIs): the MOUSEION-11 systematic review and meta-analysisElsa Vitale, Andrey Soares, Alessandro Rizzo, et al.
Anticancer Research|February 5, 2020
Specific Toxicity of Maintenance Olaparib <i>Versus</i> Placebo in Advanced Malignancies: A Systematic Review and Meta-analysisAngela Dalia Ricci, Alessandro Rizzo, Marco Novelli, et al.
Cancers|May 28, 2022
Immunotherapy in Pancreatic Cancer: Why Do We Keep Failing? A Focus on Tumor Immune Microenvironment, Predictive Biomarkers and Treatment OutcomesAlessandro Di Federico, Mirta Mosca, Rachele Pagani, et al.
Pageof 39